Women's-health guide
What GLP-1 Costs and How to Start Safely
A measured women's-lens look at GLP-1 cost and starting safely: 503A vs 503B pharmacies, LegitScript, FDA compounding and what to verify.
On this page
Our pick for women
Grade ACoreAge Rx
93/100The most reliable on-ramp for women: nationwide access to both molecules at one flat, no-surprise price — including tirzepatide, the option many women with insulin resistance want.
Check availability- Semaglutide
- $99/mo
- Tirzepatide
- $149/mo
Also worth a look
SnagRx
Grade CHolds one price at every dose and names all four of its partner pharmacies with addresses — a rare pair of disclosures, wrapped in discount theater that does not survive a second look.
Visit SnagRxWhat GLP-1 treatment costs
Cost varies widely by product and route. Brand-name semaglutide and tirzepatide are the products studied in the trials and carry the highest list prices; compounded versions are often cheaper, which for some women is the difference between starting and not1. Because prices change and differ by program, we quote them per each provider's published pricing (last reviewed 2026) rather than as fixed figures — always confirm the total monthly cost, what happens at higher doses, and whether you are committing to a long prepayment. That last one is the trap worth naming: a program can publish its prices openly and still show you only the cheapest rung of its ladder, which is the annual prepay rate rather than the month-to-month one — we take a program that advertises the twelve-month rung as its headline figure apart tier by tier so you can see how far the two diverge. Publishing the whole ladder is not by itself a fix, either: one program puts every rung of every product in the open, correctly labeled with what it bills, and still prints a single advertised figure that four of its own products cost less than — so the number on the card is worth checking against the plan selector even when the pricing looks unusually transparent. Two non-partner sellers we read in August 2026 sit at opposite ends of that spectrum: one whose three- and six-month prepay totals divide exactly into the per-month figures printed beside them, and one whose entire public price surface is seven fixed strings, headlined by a $99 that matches no program it sells. Check the unit as well as the figure, because "per month" is not always a month: a third of those sellers bills every four weeks while advertising a "/mo" rate, which is thirteen charges in a year rather than twelve, and the extra cycle only shows up on the reader who is still treating a year later. A prepayment does not have to be labeled as one to behave like one, either: a program whose advertised "$199/mo average" is a $597 charge billed every 12 weeks publishes no monthly cadence at all, so that average is the prepay divided by three — and because a 12-week cycle recurs 4.35 times a year rather than four, its own published renewal terms work out nearer $216 a month once the first-period rate has run out. The prepay-as-monthly trick can also run twice on a single page: a plan page whose hero reads "from $159/mo" and whose "entry price" cards read $199 and $249, when all three of those figures are twelve-month prepay rungs bills $279 and $349 a month if you actually pay monthly — and $1,908, $2,388 or $2,988 up front if you take the headline at its word. Then check what the plan selector has already chosen on your behalf before you arrive: one program opens with its three-month prepay pre-selected and badges every prepay tier alike as "max saving", so the default path takes $657 in one charge rather than the $249 its monthly plan costs. This guide is educational only and not medical advice.
503A vs 503B: what the pharmacy type means
When a program uses compounded medication, the kind of pharmacy matters. A 503A pharmacy compounds patient-specific prescriptions; a 503B outsourcing facility registers with the FDA and follows stricter manufacturing-quality standards. Neither makes an FDA-approved product the way a brand-name manufacturer does — the FDA does not review compounded drugs for safety and efficacy before they reach you, and it has flagged concerns with some compounded GLP-1 products23. Knowing which type of pharmacy fills your prescription is a fair question to ask, and a good program will answer it plainly.
How to verify a program before you start
Check that a licensed clinician oversees your care and is reachable for side effects and titration. Look for transparency about what product you receive and from what pharmacy. LegitScript certification and a verifiable state pharmacy license are reasonable signals that a program operates within the rules, though no badge replaces genuine oversight. Our compounded vs brand-name guide explains that trade-off, and our checklist for judging a program before you pay covers the rest of the conversation.
Starting safely, with a women's lens
Safe starting is not only about the drug — for women it includes contraception and pregnancy planning, since GLP-1 medicines are not used in pregnancy and can affect how oral contraceptives are absorbed. Baseline labs and a clear titration plan are part of a responsible start too; see our guide to what a real baseline panel includes and when it gets re-checked, and our guide to how these drugs interact with your cycle and contraception for the timing questions that come with the first dose. If you're starting or restarting postpartum, the FDA label draws a real distinction between the semaglutide tablet and the injection for breastfeeding safety, covered in our guide to GLP-1 and breastfeeding. And a genuinely safe start includes a screening question few programs ask: whether you have a current or past eating disorder, since the same appetite suppression that makes these drugs work can reinforce restriction in someone vulnerable to it — our guide to GLP-1 and eating disorder history covers what a careful intake should include. The programs that do these things well are the ones our Luna Fit Score methodology rewards. Compare on oversight and safety first, then on price — and make the final call with a clinician who can see your whole picture.
One provider holds a single price at every dose and publishes its whole commitment ladder rather than only the cheapest rung — SnagRx, reviewed here — though its headline figure is the twelve-month prepay rate, not the recurring one.
Frequently asked questions
What is the difference between a 503A and a 503B pharmacy?
A 503A pharmacy compounds patient-specific prescriptions; a 503B outsourcing facility registers with the FDA and follows stricter manufacturing-quality standards. Neither produces an FDA-approved product the way a brand-name manufacturer does.
How do I start a GLP-1 safely as a woman?
Verify licensed clinical oversight, transparent product sourcing, and reasonable signals like LegitScript certification and a valid pharmacy license. Confirm total cost, discuss contraception and pregnancy planning, and get baseline labs before starting.
References
- Wilding JPH, Batterham RL, Calanna S, et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). New England Journal of Medicine. https://doi.org/10.1056/NEJMoa2032183
- U.S. Food and Drug Administration (2024). Compounding and the FDA: Questions and Answers. FDA. https://www.fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers
- U.S. Food and Drug Administration (2024). Medications Containing Semaglutide Marketed for Type 2 Diabetes or Weight Loss. FDA. https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/medications-containing-semaglutide-marketed-type-2-diabetes-or-weight-loss
Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.
Keep exploring
Lighter You Review: A Real Operator With No Public Price
Lighter You names four pharmacies with street addresses and publishes no price you can verify. Its $99 headline buys nothing. What we found in August 2026.
Read the guide →GLP-1 Medicines, Your Cycle, and Contraception
Appetite, the menstrual cycle, birth control absorption and pregnancy — the women's-specific questions worth raising before you start a GLP-1.
Read the guide →Compounded vs Brand-Name GLP-1 for Women
What the compounded-vs-brand choice really means for women: what the evidence covers, what compounding is, and how to decide with a clinician.
Read the guide →GLP-1 Medication and Gallstones: Why Women Start From Higher Risk
GLP-1s raise gallbladder disease risk most in weight-loss trials specifically. Why estrogen already puts women 2-3x higher than men, and the symptoms to know.
Read the guide →GLP-1 Medication and Eating Disorder History: What to Ask Before You Start
GLP-1s show real promise for binge eating disorder — and the same appetite suppression can reinforce restriction in a history of anorexia. What to ask.
Read the guide →GLP-1 Medication and PCOS: What Women Should Know
How GLP-1 medicines target the insulin resistance behind PCOS weight — and the questions to ask a provider about tirzepatide, labs and androgens.
Read the guide →